INTERLEUKIN 13 (IL-13) ACTS AS A PROFIBROTIC CYTOKINE FOR RECRUITMENT OF MYOFIBROBLASTS IN ORAL SUBMUCOUS FIBROSIS

被引:1
作者
Reddy, Mamatha G. S. [1 ]
Sarode, Sachin C. [1 ]
Desai, Rajiv S. [2 ]
机构
[1] Dr DY Patil Dent Coll & Hosp, DY Patil Vidyapeeths, Pune 411018, Maharashtra, India
[2] Nair Dent Hosp & Coll, Mumbai 400008, Maharashtra, India
关键词
Interleukin; 13; myofibroblasts; oral submucous fibrosis; pathogenesis; transfouning growth factor-beta; LUNG FIBROBLASTS; TISSUE FIBROSIS; EXPRESSION; PATHOGENESIS; MECHANISMS; BETA;
D O I
10.5958/0974-4517.2019.00028.4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Oral submucous fibrosis (OSF) is a chronic inflammatory condition due to areca nut (Areca catechu) chewing which induces fibrosis leading to the difficulty in mouth opening. Various profibrotic cytokines and chemokines have been found involved in fibrosis. The present study was aimed to find the role of interleukin 13 (IL-13) in recruiting the myofibroblasts and as a causative factor for fibrosis in OSF. Twenty-five sections of OSF tissue and ten sections of normal mucosa were stained with IL -13, TGF-beta 1 and alpha-SMA antibodies using immunohistochemical method. Immunostaining was done to assess staining intensity and percentage of positive cells. The results were analyzed by SPSS software. The expression of all three markers IL-13, TGF-beta 1 and alpha-SMA showed significant difference between control and OSF (p < 0.001), control and early OSF (p < 0.001) control and advanced OSF (p < 0.001). No statistical difference was found between early OSF and advanced OSF. Significant expression of IL-13 and its correlation with TGF-beta and alpha-SMA suggests its role in pathogenesis of OSF.
引用
收藏
页码:221 / 227
页数:7
相关论文
共 29 条
  • [1] Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13
    Aliprantis, Antonios O.
    Wang, Jingsong
    Fathman, John W.
    Lemaire, Raphael
    Dorfman, David M.
    Lafyatis, Robert
    Glimcher, Laurie H.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (08) : 2827 - 2830
  • [2] Evaluation of myofibroblasts in oral submucous fibrosis: correlation with disease severity
    Angadi, Punnya V.
    Kale, Alka D.
    Hallikerimath, Seema
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2011, 40 (03) : 208 - 213
  • [3] Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma
    Blease, K
    Jakubzick, C
    Westwick, J
    Lukacs, N
    Kunkel, SL
    Hogaboam, CM
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (08) : 5219 - 5224
  • [4] Arecoline- induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1
    Chang, Yu-Chao
    Tsai, Chung-Hung
    Lai, You-Liang
    Yu, Cheng-Chia
    Chi, Wan-Yu
    Li, Jung Jung
    Chang, Wen-Wei
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2014, 18 (04) : 698 - 708
  • [5] An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response
    Chiaramonte, MG
    Donaldson, DD
    Cheever, AW
    Wynn, TA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (06) : 777 - 785
  • [6] Clive R.T., 2006, DIAGNOSTIC IMMUNOHIS, P7
  • [7] Interleukin-13-producing CD8+T cells mediate dermal fibrosis in patients with systemic sclerosis
    Fuschiotti, Patrizia
    Larregina, Adriana T.
    Ho, Johnan
    Feghali-Bostwick, Carol
    Medsger, Thomas A., Jr.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (01): : 236 - 246
  • [8] Gandhi Piyush, 2017, Dent Res J (Isfahan), V14, P314
  • [9] IL-13 Induces YY1 through the AKT Pathway in Lung Fibroblasts
    Guo, Jia
    Yao, Hongwei
    Lin, Xin
    Xu, Haodong
    Dean, David
    Zhu, Zhou
    Liu, Gang
    Sime, Patricia
    [J]. PLOS ONE, 2015, 10 (03):
  • [10] IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase-dependent pathway
    Hashimoto, S
    Gon, Y
    Takeshita, I
    Maruoka, S
    Horie, T
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (06) : 1001 - 1008